Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 23

Trial Status

Completed1
Recruiting1
Terminated1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT04329728Phase 1/2Recruiting
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Lymphoid Malignancies
PrincipalinvestigatorStart date: 2020-11-06
NCT02247843Phase 1/2Completed
Stem Cell Gene Therapy for Sickle Cell Disease
Sickle Cell Disease
PrincipalinvestigatorStart date: 2014-12-01

Research Network

Collaboration Network

96 collaborators·144 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University of California, Los Angeles

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Vincenzo Liso, MD

UO Universita degi Studi Policinico Ematologia

Related
1 trials

Shared therapeutic areas:

LeukemiaLymphoma

Worked with same sponsors:

BioCryst Pharmaceuticals
Collaborated on 1 trial
Similarity Score24%

Wendy Stock, MD

University of Chicago Hospital

Related
1 trials

Shared therapeutic areas:

LeukemiaLymphoma

Worked with same sponsors:

BioCryst Pharmaceuticals
Collaborated on 1 trial
Similarity Score24%

Vernon Louw, MD

Free State University

Related
1 trials

Shared therapeutic areas:

LeukemiaLymphoma

Worked with same sponsors:

BioCryst Pharmaceuticals
Collaborated on 1 trial
Similarity Score24%

Peter Staib, MD

Med. Klinik I / Hamatolgie

Related
1 trials

Shared therapeutic areas:

LeukemiaLymphoma

Worked with same sponsors:

BioCryst Pharmaceuticals
Collaborated on 1 trial
Similarity Score24%

Nicholas Novitzky, MD

Division of Haematology

Related
1 trials

Shared therapeutic areas:

LeukemiaLymphoma

Worked with same sponsors:

BioCryst Pharmaceuticals
Collaborated on 1 trial
Similarity Score24%

Gerhard Ehninger, MD

Klinikum Carl Gustav Carus der Technischen Universitat

Related
1 trials

Shared therapeutic areas:

LeukemiaLymphoma

Worked with same sponsors:

BioCryst Pharmaceuticals
Collaborated on 1 trial
Similarity Score24%

Belinda Pinto Simoes, MD

Hospital das Clinicas de Faculdade de Medicina de Ribeirao Preto

Related
1 trials

Shared therapeutic areas:

LeukemiaLymphoma

Worked with same sponsors:

BioCryst Pharmaceuticals
Collaborated on 1 trial
Similarity Score24%

David Barqueti Jendiroba, MD

Centro Goiano de Oncologia

Related
1 trials

Shared therapeutic areas:

LeukemiaLymphoma

Worked with same sponsors:

BioCryst Pharmaceuticals
Collaborated on 1 trial
Similarity Score24%

Aleksander Skotnicki, MD

Katedra i Klinika Hematologii Collegium Medicum

Related
1 trials

Shared therapeutic areas:

LeukemiaLymphoma

Worked with same sponsors:

BioCryst Pharmaceuticals
Collaborated on 1 trial
Similarity Score24%

Renato Bassan, MD

Dipartimento di Oncoloia ed Ematico

Related
1 trials

Shared therapeutic areas:

LeukemiaLymphoma

Worked with same sponsors:

BioCryst Pharmaceuticals
Collaborated on 1 trial
Similarity Score24%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT04329728Phase 1/2PrincipalInvestigator

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

Lymphoid Malignancies
Recruiting
NCT02247843Phase 1/2PrincipalInvestigator

Stem Cell Gene Therapy for Sickle Cell Disease

Sickle Cell Disease
Completed
NCT00419081Phase 2PrincipalInvestigator

Study of Forodesine Hydrochloride in Patients With Relapsed/Refractory Precursor T-Lymphoblastic Leukemia/Lymphoma Who Have Failed Two or More Prior Treatment Regimens

LeukemiaLymphoma
Terminated

All 3 trials loaded